The results suggested that daphnetin inhibited the migration and invasion of lung adenocarcinoma A549 cells to affect tumor progression, while the JNK inhibitor could inhibit cell migration by inhibiting the reduction of the scratch area. The gene discussed is MAPK8; the disease is lung adenocarcinoma.